Multiple Sclerosis After Infectious Mononucleosis
The DOI matches its Crossref record.
Abstract
BACKGROUND: Infectious mononucleosis caused by the Epstein-Barr virus has been associated with increased risk of multiple sclerosis. However, little is known about the characteristics of this association. OBJECTIVE: To assess the significance of sex, age at and time since infectious mononucleosis, and attained age to the risk of developing multiple sclerosis after infectious mononucleosis. DESIGN: Cohort study using persons tested serologically for infectious mononucleosis at Statens Serum Institut, the Danish Civil Registration System, the Danish National Hospital Discharge Register, and the Danish Multiple Sclerosis Registry. SETTING: Statens Serum Institut. PATIENTS: A cohort of 25 234 Danish patients with mononucleosis was followed up for the occurrence of multiple sclerosis beginning on April 1, 1968, or January 1 of the year after the diagnosis of mononucleosis or after a negative Paul-Bunnell test result, respectively, whichever came later and ending on the date of multiple sclerosis diagnosis, death, emigration, or December 31, 1996, whichever came first. MAIN OUTCOME MEASURE: The ratio of observed to expected multiple sclerosis cases in the cohort (standardized incidence ratio). RESULTS: A total of 104 cases of multiple sclerosis were observed during 556,703 person-years of follow-up, corresponding to a standardized incidence ratio of 2.27 (95% confidence interval, 1.87-2.75). The risk of multiple sclerosis was persistently increased for more than 30 years after infectious mononucleosis and uniformly distributed across all investigated strata of sex and age. The relative risk of multiple sclerosis did not vary by presumed severity of infectious mononucleosis. CONCLUSIONS: The risk of multiple sclerosis is increased in persons with prior infectious mononucleosis, regardless of sex, age, and time since infectious mononucleosis or severity of infection. The risk of multiple sclerosis may be increased soon after infectious mononucleosis and persists for at least 30 years after the infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., et al. (2022) · Science · doi:10.1126/science.abj8222 · Cited by 2,049
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Ramagopalan, S. V., Dobson, R., Meier, U. C., & Giovannoni, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70094-6 · Cited by 548
The epidemiology of multiple sclerosis
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 514
Antiviral immune responses: triggers of or triggered by autoimmunity?
Münz, C., Lünemann, J. D., Getts, M. T., & Miller, S. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2527 · Cited by 480
Primary infection with the Epstein‐Barr virus and risk of multiple sclerosis
Levin, L. I., Munger, K. L., O'Reilly, E. J., Falk, K. I., & Ascherio, A. (2010) · Annals of Neurology · doi:10.1002/ana.21978 · Cited by 404
An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis
Handel, A. E., Williamson, A. J., Disanto, G., Handunnetthi, L., Giovannoni, G., & Ramagopalan, S. V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012496 · Cited by 343
Lünemann, J. D., Jelčić, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martin, R., & Münz, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072397 · Cited by 334
Virus infection, antiviral immunity, and autoimmunity
Getts, D. R., Chastain, E. M. L., Terry, R. L., & Miller, S. D. (2013) · Immunological Reviews · doi:10.1111/imr.12091 · Cited by 299
Environmental factors and their timing in adult-onset multiple sclerosis
Handel, A. E., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.1 · Cited by 263
Epstein–Barr Virus Infection and Multiple Sclerosis: A Review
Ascherio, A., & Munger, K. L. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9201-3 · Cited by 259
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
Bjornevik, K., Münz, C., Cohen, J. I., & Ascherio, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00775-5 · Cited by 246
Onisiforou, A., & Spyrou, G. M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab141 · Cited by 23
“The viral infectious hypothesis of NDs is best supported in the case of MS as viral infections are the strongest environmental risk factor associated with its development, with Epstein– Barr virus (EBV) infection showing the strongest association [18, 28].”
Background
Metadata
- Authors
- Nielsen, T. R., Rostgaard, K., Nielsen, N. M., Koch-Henriksen, N., Haahr, S., Sørensen, P. S., & Hjalgrim, H.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-01-01
- Volume
- 64
- Issue
- 1
- Pages
- 72
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2145015886
- Cited by
- 214
- References
- 0
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.